Complementary demonstrations that IL-17A and IL-22 production were significantly lower following stimulation of B cell-depleted PBMCs of T2D subjects independently supported the idea that B cells activate Th17s in T2D (42, 74). This evidence concerns the gene IL22 and type 2 diabetes mellitus.